Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe

MT Newswires Live

2025/06/05

China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.

The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.

The company's shares closed over 1% lower.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2541047603"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541047603\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541047603?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541047603","market":"sg","top_or_hot":-1,"title":"Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe","media":"MT Newswires Live","content":"<html><body><p> China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.</p><p>The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.</p><p>The company's shares closed over 1% lower.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNortheast Pharmaceutical Gets Nod to Market Antiobiotic in Europe\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-06-05 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.</p><p>The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.</p><p>The company's shares closed over 1% lower.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"000597","symbol_name":"东北制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2541047603","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541047603","pubTimestamp":1749113109,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China's Northeast Pharmaceutical Group  is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.The company's shares closed over 1% lower.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"000597":"东北制药","BK0191":"维生素","BK0239":"医药制造","NBN":"东北银行","BK4211":"区域性银行"},"translate_title":"东北制药获准在欧洲销售抗生素","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000597":0.9,"NBN":1},"content_text":"China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.The company's shares closed over 1% lower.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}